Nanjing Ruiying Runze Biopharmaeutical Technology Co., Inc.

Nanjing Ruiying Runze Biopharmaceutical Technology Co., Inc.

Shandong Runze Pharmaceuticals Co., Ltd.

Jing Shang

Jun Liu

Tao Wang

Lin Ding

Yu Li

Dongsheng Yu

Sha Liao

Qian Wang

Yu Jin

Jia Zhou

Huali Wu

Liangliang Zhou

Youqing Tian

Ting He

Guohong Qin

Xiaoli Tian

Guorui Zhao

Hui Zhong

Junyi Zhu

Silin Chong

Disclosed are a compound pharmaceutical composition containingBoiss et Hout as a lipid-lowering active ingredient and the use of the composition for preparing a drug for treating or preventing lipid metabolism disorders, wherein the composition comprises a pharmaceutically active ingredient and a pharmaceutically acceptable carrier, wherein the pharmaceutically active ingredient consists of quercetin-3-O-&#x3b2;-D-glucuronoside, isoquercitrin and quercetin at a molar ratio of 1.1-2.4:1.3-3.3:1.2-3.1.

Compatible composition containing chinese medicine cichorium glandulosum boiss et hout as lipid-lowering active ingredient

Disclosed is a composition containing active components ofL. against myocardial ischemia-reperfusion injury (MIRI). The composition consists of active components and a pharmaceutically acceptable carrier, wherein the active components comprise luteolin, kaempferol and luteolin-7-O-glucoside. Pharmacodynamic experiments show that these three components can be combined together to synergistically treat myocardial ischemia-reperfusion injury.

Composition containing active components ofL. against myocardial ischemia-reperfusion injury

The present disclosure provides methods and pharmaceutical compositions for treating depigmentation diseases such as vitiligo or leukoctricia. The pharmaceutical composition contains a therapeutically effective amount of fluoxetine.

Application of fluoxetine to treatment of depigmentation diseases

Growing community of inventors

Jiangsu, China

Jing Shang